DISP3
gene geneOn this page
Also known as KIAA1337
Summary
DISP3 (dispatched RND transporter family member 3, HGNC:29251) is a protein-coding gene on chromosome 1p36.22, encoding Protein dispatched homolog 3 (Q9P2K9). Plays a role in neuronal proliferation and differentiation.
Involved in negative regulation of neuron differentiation; positive regulation of lipid metabolic process; and positive regulation of neural precursor cell proliferation. Located in cytoplasm.
Source: NCBI Gene 57540 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 65 total
- MANE Select transcript:
NM_020780
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29251 |
| Approved symbol | DISP3 |
| Name | dispatched RND transporter family member 3 |
| Location | 1p36.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1337 |
| Ensembl gene | ENSG00000204624 |
| Ensembl biotype | protein_coding |
| OMIM | 611251 |
| Entrez | 57540 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000294484, ENST00000304391, ENST00000423056, ENST00000922103, ENST00000922104, ENST00000922105
RefSeq mRNA: 1 — MANE Select: NM_020780
NM_020780
CCDS: CCDS41247
Canonical transcript exons
ENST00000294484 — 21 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001065687 | 11515369 | 11515503 |
| ENSE00001065688 | 11519355 | 11519503 |
| ENSE00001065696 | 11519719 | 11519880 |
| ENSE00001065698 | 11525176 | 11525312 |
| ENSE00001065699 | 11502678 | 11502897 |
| ENSE00001065701 | 11514390 | 11514526 |
| ENSE00001065702 | 11523942 | 11524055 |
| ENSE00001065703 | 11520687 | 11520848 |
| ENSE00001065705 | 11516001 | 11516161 |
| ENSE00001065707 | 11517463 | 11517602 |
| ENSE00001506257 | 11531565 | 11531710 |
| ENSE00001506258 | 11530907 | 11531033 |
| ENSE00001506259 | 11529787 | 11529959 |
| ENSE00001506260 | 11529556 | 11529686 |
| ENSE00001506261 | 11526651 | 11526835 |
| ENSE00001662541 | 11500990 | 11502088 |
| ENSE00001706216 | 11479155 | 11479372 |
| ENSE00001783669 | 11536324 | 11537551 |
| ENSE00003464077 | 11534381 | 11534540 |
| ENSE00003637510 | 11535011 | 11535124 |
| ENSE00003674493 | 11535478 | 11535644 |
Expression profiles
Bgee: expression breadth broad, 96 present calls, max score 96.19.
FANTOM5 (CAGE): breadth broad, TPM avg 3.2115 / max 211.2762, expressed in 514 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 618 | 3.1830 | 508 |
| 619 | 0.0179 | 8 |
| 620 | 0.0106 | 5 |
Top tissues by expression
204 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 96.19 | gold quality |
| cortical plate | UBERON:0005343 | 83.35 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.38 | gold quality |
| putamen | UBERON:0001874 | 76.41 | gold quality |
| caudate nucleus | UBERON:0001873 | 76.39 | gold quality |
| ventricular zone | UBERON:0003053 | 75.54 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.07 | gold quality |
| nucleus accumbens | UBERON:0001882 | 74.81 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 72.67 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.00 | gold quality |
| amygdala | UBERON:0001876 | 71.83 | gold quality |
| right testis | UBERON:0004534 | 71.82 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.47 | gold quality |
| left testis | UBERON:0004533 | 71.29 | gold quality |
| neocortex | UBERON:0001950 | 70.83 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 70.78 | gold quality |
| forebrain | UBERON:0001890 | 70.74 | gold quality |
| hypothalamus | UBERON:0001898 | 70.57 | gold quality |
| frontal cortex | UBERON:0001870 | 70.44 | gold quality |
| cerebral cortex | UBERON:0000956 | 70.30 | gold quality |
| prefrontal cortex | UBERON:0000451 | 70.26 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 70.07 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 70.05 | gold quality |
| brain | UBERON:0000955 | 69.96 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 69.59 | gold quality |
| temporal lobe | UBERON:0001871 | 69.53 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 69.43 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 69.36 | gold quality |
| testis | UBERON:0000473 | 68.88 | gold quality |
| occipital lobe | UBERON:0002021 | 68.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.77 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
40 targeting DISP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-18A-5P | 99.29 | 71.05 | 806 |
| HSA-MIR-18B-5P | 99.29 | 71.05 | 806 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-4735-3P | 99.14 | 69.85 | 777 |
| HSA-MIR-622 | 98.99 | 66.48 | 1050 |
| HSA-MIR-6737-3P | 98.95 | 68.56 | 1577 |
| HSA-MIR-7157-3P | 98.95 | 68.70 | 1582 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-5008-3P | 98.73 | 67.50 | 1433 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
| HSA-MIR-3184-5P | 98.56 | 67.13 | 1491 |
| HSA-MIR-1237-3P | 98.55 | 67.65 | 1423 |
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-4660 | 97.79 | 67.44 | 1328 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
Literature-anchored findings (GeneRIF, showing 3)
- patched domain containing 2 (PTCHD2), yielded a statistically significant P-value of 2.5 x 10(-6) (OR = 0.27) with fewer individuals classified as exhibiting symptoms of dependence to ultraviolet light, a known carcinogen, in the context of tanning (PMID:25041255)
- impact of DISP3 on the proliferation and differentiation of neural precursors (PMID:25281927)
- our findings imply that DISP3 may help dictate the NSC cell fate to either undergo self-renewal or switch to the terminal differentiation cell program. (PMID:28134287)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | disp3 | ENSDARG00000036999 |
| mus_musculus | Disp3 | ENSMUSG00000041544 |
| rattus_norvegicus | Disp3 | ENSRNOG00000026447 |
| drosophila_melanogaster | ptc | FBGN0003892 |
| drosophila_melanogaster | disp | FBGN0029088 |
| drosophila_melanogaster | Ptr | FBGN0262867 |
| caenorhabditis_elegans | WBGENE00004208 | |
| caenorhabditis_elegans | WBGENE00004211 | |
| caenorhabditis_elegans | ptr-17 | WBGENE00004231 |
Paralogs (10): NPC1L1 (ENSG00000015520), SCAP (ENSG00000114650), PTCH2 (ENSG00000117425), DISP2 (ENSG00000140323), NPC1 (ENSG00000141458), DISP1 (ENSG00000154309), PTCHD1 (ENSG00000165186), PTCHD3 (ENSG00000182077), PTCH1 (ENSG00000185920), PTCHD4 (ENSG00000244694)
Protein
Protein identifiers
Protein dispatched homolog 3 — Q9P2K9 (reviewed: Q9P2K9)
Alternative names: Patched domain-containing protein 2
All UniProt accessions (2): Q9P2K9, Q9UJD7
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in neuronal proliferation and differentiation. Plays a role in the accumulation of cellular cholesterol. Involved in intracellular lipid droplet formation. May contribute to cholesterol homeostasis in neuronal cells.
Subcellular location. Endoplasmic reticulum membrane. Nucleus membrane. Cytoplasmic vesicle membrane.
Tissue specificity. Expressed in brain and testis.
Domain organisation. The SSD (sterol-sensing) domain is necessary for the increase in cellular cholesterol uptake.
Induction. Up-regulated by thyroid hormone T3.
Similarity. Belongs to the patched family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P2K9-1 | 1 | yes |
| Q9P2K9-2 | 2 |
RefSeq proteins (1): NP_065831* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000731 | SSD | Domain |
| IPR004869 | MMPL_dom | Domain |
| IPR042480 | DISP3 | Family |
| IPR053954 | DUF7023 | Domain |
| IPR053958 | HMGCR/SNAP/NPC1-like_SSD | Domain |
Pfam: PF03176, PF12349, PF22894
UniProt features (39 total): topological domain 13, transmembrane region 12, sequence variant 6, region of interest 2, glycosylation site 2, chain 1, domain 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P2K9-F1 | 70.84 | 0.11 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 163, 1021
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 72 (showing top):
GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_STEROL_HOMEOSTASIS, GOBP_NEUROGENESIS, GOBP_LIPID_HOMEOSTASIS, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS, GOBP_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION, GOBP_LIPID_METABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, GOBP_SMOOTHENED_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS, GOBP_REGULATION_OF_TRANSPORT, GOBP_LIPID_LOCALIZATION, GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION
GO Biological Process (10): smoothened signaling pathway (GO:0007224), cholesterol metabolic process (GO:0008203), cell differentiation (GO:0030154), regulation of lipid transport (GO:0032368), cholesterol homeostasis (GO:0042632), negative regulation of neuron differentiation (GO:0045665), positive regulation of lipid metabolic process (GO:0045834), positive regulation of neural precursor cell proliferation (GO:2000179), lipid metabolic process (GO:0006629), steroid metabolic process (GO:0008202)
GO Molecular Function (0):
GO Cellular Component (8): cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), cytoplasmic vesicle membrane (GO:0030659), nuclear membrane (GO:0031965), nucleus (GO:0005634), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| lipid metabolic process | 2 |
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| intracellular membrane-bounded organelle | 2 |
| organelle membrane | 2 |
| cell surface receptor signaling pathway | 1 |
| sterol metabolic process | 1 |
| secondary alcohol metabolic process | 1 |
| cellular developmental process | 1 |
| lipid transport | 1 |
| regulation of transport | 1 |
| regulation of lipid localization | 1 |
| sterol homeostasis | 1 |
| neuron differentiation | 1 |
| negative regulation of cell differentiation | 1 |
| regulation of neuron differentiation | 1 |
| positive regulation of metabolic process | 1 |
| regulation of lipid metabolic process | 1 |
| positive regulation of cell population proliferation | 1 |
| neural precursor cell proliferation | 1 |
| regulation of neural precursor cell proliferation | 1 |
| primary metabolic process | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| vesicle membrane | 1 |
| cytoplasmic vesicle | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
682 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DISP3 | UBIAD1 | Q9Y5Z9 | 951 |
| DISP3 | FBXO2 | Q9UK22 | 872 |
| DISP3 | PTCHD4 | Q6ZW05 | 601 |
| DISP3 | PTCHD1 | Q96NR3 | 553 |
| DISP3 | DISP1 | Q96F81 | 458 |
| DISP3 | MED22 | Q15528 | 455 |
| DISP3 | HECW2 | Q9P2P5 | 444 |
| DISP3 | KANSL3 | Q9P2N6 | 423 |
| DISP3 | NFU1 | Q9UMS0 | 423 |
| DISP3 | GRSF1 | Q12849 | 413 |
| DISP3 | UBL4B | Q8N7F7 | 407 |
| DISP3 | ZNF536 | O15090 | 400 |
| DISP3 | C9orf78 | Q9NZ63 | 388 |
| DISP3 | AAK1 | Q2M2I8 | 384 |
| DISP3 | DISP2 | A7MBM2 | 377 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DISP3 | RPS14 | psi-mi:“MI:0915”(physical association) | 0.400 |
| DISP3 | DDX21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MTNR1B | DISP3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MYCBP | DISP3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DISP3 | RASGRP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DISP3 | CA2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): PTCHD2 (Two-hybrid), PTCHD2 (Two-hybrid), PTCHD2 (Two-hybrid), PTCHD2 (Proximity Label-MS), PTCHD2 (Proximity Label-MS), PTCHD2 (Positive Genetic)
ESM2 similar proteins: A0JPH4, A2AGX3, A2RRU4, A3KFU9, A6QM06, A7YWH3, B9U3F2, G5E8P0, O15040, O75129, P97260, Q12770, Q17RG1, Q2M3C6, Q2R2B1, Q32KQ7, Q4R5A4, Q562E2, Q5M9F0, Q5MNU5, Q5RA50, Q5SYB0, Q6GQT6, Q6L8S8, Q6L9W6, Q6PCP7, Q80TL0, Q80Z10, Q80Z30, Q86V42, Q8BHR8, Q8BZB3, Q8C0R7, Q8CIV2, Q8JZL1, Q8K0Z9, Q8K451, Q8NFM7, Q8NFN8, Q8VZJ0
Diamond homologs: A3KFU9, B9U3F2, Q9P2K9, Q9Y6C5, H2L0G5, O35595, O42334, O42335, P18502, Q09614, Q0EEE2, Q13635, Q3KNS1, Q61115, Q90693, Q98864
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 21 |
| Benign | 20 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4219 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:11479369:CGAGG:C | donor_loss | 1.0000 |
| 1:11479370:GAGGT:G | donor_loss | 1.0000 |
| 1:11479373:G:GG | donor_gain | 1.0000 |
| 1:11479373:GT:G | donor_loss | 1.0000 |
| 1:11479374:T:G | donor_loss | 1.0000 |
| 1:11502674:GCA:G | acceptor_loss | 1.0000 |
| 1:11502675:CA:C | acceptor_loss | 1.0000 |
| 1:11502676:A:AG | acceptor_gain | 1.0000 |
| 1:11502677:G:GA | acceptor_gain | 1.0000 |
| 1:11502677:G:GC | acceptor_loss | 1.0000 |
| 1:11502677:GGCT:G | acceptor_gain | 1.0000 |
| 1:11502894:CCAG:C | donor_loss | 1.0000 |
| 1:11502898:G:GG | donor_gain | 1.0000 |
| 1:11502899:T:G | donor_loss | 1.0000 |
| 1:11514371:A:AG | acceptor_gain | 1.0000 |
| 1:11514372:C:G | acceptor_gain | 1.0000 |
| 1:11514385:CCCAG:C | acceptor_loss | 1.0000 |
| 1:11514386:CCAGC:C | acceptor_loss | 1.0000 |
| 1:11514388:A:AG | acceptor_gain | 1.0000 |
| 1:11514389:G:GA | acceptor_gain | 1.0000 |
| 1:11514389:GCAAA:G | acceptor_gain | 1.0000 |
| 1:11514522:CTCAG:C | donor_loss | 1.0000 |
| 1:11514524:CAGG:C | donor_loss | 1.0000 |
| 1:11514525:AGGTA:A | donor_loss | 1.0000 |
| 1:11514526:GGTA:G | donor_loss | 1.0000 |
| 1:11514527:G:C | donor_loss | 1.0000 |
| 1:11514528:T:A | donor_loss | 1.0000 |
| 1:11515501:TTGG:T | donor_loss | 1.0000 |
| 1:11515502:TGG:T | donor_loss | 1.0000 |
| 1:11515503:GGT:G | donor_loss | 1.0000 |
AlphaMissense
9005 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:11501935:T:A | C315S | 1.000 |
| 1:11501935:T:C | C315R | 1.000 |
| 1:11501936:G:A | C315Y | 1.000 |
| 1:11501936:G:C | C315S | 1.000 |
| 1:11501937:C:G | C315W | 1.000 |
| 1:11501989:T:A | C333S | 1.000 |
| 1:11501989:T:C | C333R | 1.000 |
| 1:11501990:G:C | C333S | 1.000 |
| 1:11502765:T:C | L395P | 1.000 |
| 1:11514478:A:C | S469R | 1.000 |
| 1:11514480:C:A | S469R | 1.000 |
| 1:11514480:C:G | S469R | 1.000 |
| 1:11515485:T:C | F524L | 1.000 |
| 1:11515487:C:A | F524L | 1.000 |
| 1:11515487:C:G | F524L | 1.000 |
| 1:11516007:A:T | D532V | 1.000 |
| 1:11520833:T:C | C783R | 1.000 |
| 1:11520842:T:C | C786R | 1.000 |
| 1:11520844:T:G | C786W | 1.000 |
| 1:11501809:T:A | W273R | 0.999 |
| 1:11501809:T:C | W273R | 0.999 |
| 1:11501811:G:C | W273C | 0.999 |
| 1:11501811:G:T | W273C | 0.999 |
| 1:11501822:T:C | L277P | 0.999 |
| 1:11501861:T:C | F290S | 0.999 |
| 1:11501876:T:C | L295P | 0.999 |
| 1:11501932:T:C | F314L | 0.999 |
| 1:11501934:C:A | F314L | 0.999 |
| 1:11501934:C:G | F314L | 0.999 |
| 1:11501936:G:T | C315F | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000262866 (1:11508752 C>A,G), RS1000313115 (1:11500921 C>T), RS1000336271 (1:11477613 C>G,T), RS1000491241 (1:11482808 G>A,T), RS1000500704 (1:11484407 T>C), RS1000515791 (1:11502615 T>C), RS1000653206 (1:11502304 G>T), RS1000722183 (1:11517050 T>A,G), RS1000780935 (1:11508486 T>C), RS1000825985 (1:11525137 G>A), RS1000906080 (1:11484099 G>A), RS1000914614 (1:11512257 GT>G,GTT), RS1001034560 (1:11494277 G>C), RS1001088310 (1:11494025 C>T), RS1001129632 (1:11496490 C>T)
Disease associations
OMIM: gene MIM:611251 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010219_2 | Attention deficit hyperactivity disorder (inattention symptoms) | 6.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation, increases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| Valproic Acid | affects expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| licochalcone B | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Cytarabine | increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.